Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
-fed systems. The project will be jointly supervised by Dr Yagya Regmi and Prof Laurie King. This new project will be highly collaborative and interactive, and so you will have the opportunity to learn
-
The research group of Distributed Ledger Technology and Fintech (Prof. Fabian Schär) of the Faculty of Business and Economics at the University of Basel invites applications for a PhD position with
-
TUD Dresden University of Technology, as a University of Excellence, is one of the leading and most dynamic research institutions in the country. For TUD diversity is an essential feature and a
-
22 Aug 2025 Job Information Organisation/Company University of Antwerp Research Field Computer science » Programming Computer science » Other Engineering » Electrical engineering Engineering » Other
-
Description TUD Dresden University of Technology, as a University of Excellence, is one of the leading and most dynamic research institutions in the country. For TUD diversity is an essential
-
27 Aug 2025 Job Information Organisation/Company ETH Zürich Research Field Engineering » Other Mathematics » Applied mathematics Mathematics » Computational mathematics Mathematics » Mathematical
-
. The successful candidate will be based in the Mechanical and Aerospace Systems research group (previously known as G2TRC) within the faculty of Engineering and will be part of a supportive team of 50 researchers
-
or to TU Dresden,Professur für Theoretische Chemie, Herrn Prof. Thomas Heine, Helmholtzstr. 10, 01069 Dresden, Germany. Please submit copies only, as your application will not be returned to you. Expenses
-
Successful candidates will join the young, vibrant, and interdisciplinary FINATRAX Research Group, which builds bridges between business research and information systems engineering. The group
-
://www.bioengineering.dtu.dk/research/research-sections/section-for-protein-chemistry-and-enzyme-technology/interfacial-enzymology En’Zync is a visionary research center led by Prof. Daniel Otzen, funded by the Novo Nordisk